Merge 104.8 | 07 June 2020
A number of officials in the private sector have praised the national efforts made by the Ministry of Commerce and Industry (MoCI) in cooperation with the relevant government agencies, towards limiting the spread the COVID-19 novel coronavirus.
As Oman News Agency (ONA) reports, medicines in the Sultanate were manufactured at a steady pace, with local factories surpassing existing pharmaceutical industry scope and, instead, moving forward towards innovation and research.
Efforts by Omani factories operating in the field of manufacturing tools and various locally-made medical pharmaceuticals (masks, gloves, disinfectants etc.) were also praised.
Eng. Said bin Nasser al-Rashdi, CEO of the Omani Industrialists Association (OIA), said that the MoCI played a significant role in overcoming the challenges facing local factories — as it is the first sponsor of the sector. He pointed out that the OIA made an effort to help factories continue to work under the current conditions, and negotiated with concerned stakeholders about safety and security requirements with minimal impact on plant operations.
Khalid bin Rashid al-Omairi of Al Bahjah Group, which includes both the Oman Hygienic Products and Oman Pharmaceutical Products, said: “The coronavirus pandemic crisis contributed to encouraging investors to invest in medical supplies, and get to know the local companies that manufacture these products in the Sultanate. It also unveiled a highly efficient Omani cadre capable of leadership in the field of manufacturing medical materials.”
Source: ONA
(Also read: Oman imposes restrictions on cosmetics containing hydroquinone and mercury.)